Lupin Q3 results: Net jumps 300% to Rs 613 cr on back of record sales
North America sales for Q3 FY 2024 were Rs 1,888.5 crore, up 23.7 per cent Y-o-Y. North America accounted for
Continue readingThe Number One Finance & Business Blog!
North America sales for Q3 FY 2024 were Rs 1,888.5 crore, up 23.7 per cent Y-o-Y. North America accounted for
Continue readingLupin: The pharma major has received approval from the U.S. FDA for Bromfenac Ophthalmic Solution, 0.07%, and tentative approval from
Continue readingSensex, Nifty updates on 08 September 2023: From the Sensex pack, NTPC, Tata Motors, Larsen & Toubro, Bajaj Finserv, Bharti
Continue reading